2017
DOI: 10.1016/j.tmaid.2017.06.003
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiological profile of cutaneous larva migrans in travelers returning to France between 2003 and 2015

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 18 publications
0
8
0
1
Order By: Relevance
“…CLM is a parasitic disease that occurs in tropical and subtropical regions 1. It is caused by skin penetration of hookworm larvae that usually infest cats, dogs, and other animals.…”
Section: Answermentioning
confidence: 99%
See 1 more Smart Citation
“…CLM is a parasitic disease that occurs in tropical and subtropical regions 1. It is caused by skin penetration of hookworm larvae that usually infest cats, dogs, and other animals.…”
Section: Answermentioning
confidence: 99%
“…Vesiculobullous lesions occur in 9-15% of cases and sometimes reach a large size (several centimetres in diameter) 234. Bacterial superinfection is possible (9-24% of cases in Brazil), commonly as a result of lesions being scratched 1…”
Section: Answermentioning
confidence: 99%
“…Undoubtedly, this approval will facilitate more timely access to ivermectin for treatment of both simple and severe strongyloidiasis, which is likely to reduce related morbidity and mortality, particularly as it might be better integrated into pre-immunosuppression screening programs (e.g., in advance of solid organ transplant or cancer chemotherapy). Similarly, off-label treatment can now be expedited for cutaneous larva migrans in primary care settings, where most such patients are encountered [25]. Ivermectin accessibility in the context of scabies outbreaks at long-term care facilities could also potentially provide infection prevention and control benefits unrealized prior to 2018 due to the lack of drug availability.…”
Section: Hot Topic 1: Approval Of Ivermectin For Strongyloidiasis By mentioning
confidence: 99%
“…Besides large international network analyses, we conducted single-centre and multicentre studies on specific destinations including the Comoro Islands [1] , Senegal [15] and North Africa [16] , [17] , as well as on specific diseases, including loiasis [18] , schistosomiasis in Corsica [19] , larva migrans [20] , and rabies and exposure to rabies [21] , [22] . Additionally, our laboratory is associated with the national reference centre for malaria.…”
Section: Travel Medicine and Migrant Healthmentioning
confidence: 99%